Cleared Traditional

K031560 - BAYER RAPIDLAB 1200 SYSTEM

K031560 is an FDA 510(k) clearance for BAYER RAPIDLAB 1200 SYSTEM, manufactured by Bayer Healthcare, LLC. The device is a Class 2 Chemistry device with product code CHL cleared through the Traditional 510(k) pathway after a 212-day FDA review.

K031560 · Bayer Healthcare, LLC · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2003
Decision
212d
Days
Class 2
Risk

K031560 is an FDA 510(k) clearance for the BAYER RAPIDLAB 1200 SYSTEM. Classified as Electrode Measurement, Blood-gases (pco2, Po2) And Blood Ph (product code CHL), Class II - Special Controls.

Submitted by Bayer Healthcare, LLC (Medfield, US). The FDA issued a Cleared decision on December 17, 2003 after a review of 212 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1120 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Bayer Healthcare, LLC devices

FDA 510(k) Submission Details - K031560

510(k) Number K031560 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 19, 2003
Decision Date December 17, 2003
Days to Decision 212 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
124d slower than avg
Panel avg: 88d · This submission: 212d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CHL Device Classification - Class 2, Special Controls

Product Code CHL Electrode Measurement, Blood-gases (pco2, Po2) And Blood Ph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1120
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CHL Electrode Measurement, Blood-gases (pco2, Po2) And Blood Ph

All 151
Devices cleared under the same product code (CHL) and FDA review panel - the closest regulatory comparables to K031560.
ABL800 FLEX WITH FLEXQ MODULE, MODEL ABL8XX
K043218 · Radiometer Medical Aps · May 2005
OMNI MODULAR, OMNI C AND OMNI S ANALYZER (PH ELECTRODE)
K050423 · Roche Diagnostics · Apr 2005
ABL800 FLEX
K041874 · Radiometer Medical Aps · Oct 2004
STAT PROFILE PHOX PLUS L ANALYZER
K023567 · Nova Biomedical Corp. · Dec 2002
STAT PROFILE CRITICAL CARE XPRESS ANALYZER
K022746 · Nova Biomedical Corp. · Nov 2002
STAT PROFILE PHOX PLUS C ANALYZER
K021713 · Nova Biomedical Corp. · Jul 2002